N/A
N=44
A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer
Esophageal Neoplasms
Bottom Line
View on ClinicalTrials.gov: NCT02182804 ↗Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcome: Primary: Accuracy — 89; 70 Percentage of accuracy
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Olympus (Device); Cellvizio (Device)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- King Chulalongkorn Memorial Hospital
- Primary completion
- Jun 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Accuracy |
89; 70 | — |
Summary
This descriptive cross sectional study aims to directly compare the diagnostic capability of the probed-based confocal laser endomicroscopy (pCLE) and the magnifying narrow band imaging (M-NBI) in the Lugol's voiding lesions.
Eligibility Criteria
Inclusion Criteria
- Age over 20 years
- Having histological-confirmed diagnosis of head and neck cancer
- Having no esophageal symptoms
Exclusion Criteria
- Having index cancer of nasopharynx
- History of esophageal surgery
- Having esophageal stricture or obstruction
- Having esophageal varices
- Known case of esophageal cancer
- Uncorrectable coagulopathy and thrombocytopenia
- Pregnancy
- Thyrotoxicosis
- Creatinine clearance less than 30 ml/min
- Allergy to iodine or fluorescein.
Data sourced from ClinicalTrials.gov (NCT02182804). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.